Pharmaceuticals

"Pharmaceuticals" Main

Latest Morning Briefing Stories

Hospitals, Doctors Relying On Rationing Amid Severe Shortage Of Lifesaving Immune Globulin

KHN Morning Briefing

Manufacturers say the current shortage is among the worst they have experienced since the popular, wide-ranging treatment came to market. In other pharmaceutical news: Sen. Bill Cassidy (R-La.) touts value-based payments for cutting drug costs; a new approach to gene therapy offers tentative hope; a controversy arises over a pre-term birth medication; and more.

Physician Goes Behind The Scenes To Write Compelling Story About Treating Patients With New Cancer Gene Therapy

KHN Morning Briefing

Ilana Yurkiewicz, a physician and medical journalist at Stanford University, explains why CAR-T is only used in patients with certain cancers and tries to answer why they haven’t yet been shown to work against solid tumors in an UnDark article. Public health news is on breast cancer tests, fecal matter transplants, Zantac recalls, white male life expectancy, skin rashes, growing up with HIV, a retracted HIV study, live-streaming a mammogram, and how to get a good night’s sleep, as well.

Rift Between Insurance Industry, Pharma On Full Display As Sides Debate Democrats’ Plan To Lower Drug Prices

KHN Morning Briefing

When it comes to high health care costs, the big players in the industry often point fingers at each other as the culprits, which can make coming to a consensus on lowering costs challenging. The debate was on display at the final panel of the Milken Institute’s Future of Health Summit Wednesday, with insurers and pharma representatives sparring over the Democrats’ plan. Meanwhile, lawmakers introduce a bipartisan measure to tackle generic drug costs for seniors.

In Opioid Court Battle, A Nationwide Settlement Could Be Years Away Or Even A Pipe Dream. So What Happens In The Meantime?

KHN Morning Briefing

The opioid crisis is still claiming 100 lives a day, and yet it’s unclear if states, counties or local governments will see money from drugmakers anytime soon. And even the most optimistic projections in a possible nationwide settlement would be a drop in the bucket for what it would cost states to tackle the epidemic. Experts say the country will be dealing with the fallout for decades to come.

Could CRISPR Technology Rise As A Hero In The Era Of Antibiotic Resistance?

KHN Morning Briefing

CRISPR has been making waves with its success in fighting rare genetic diseases, but could it also help turn bacterium’s machinery against itself? In the era of superbugs, scientists are hopeful the technology can be a game-changer. Meanwhile, GSK has announced a late-stage study for its new antibiotic to fight urinary tract infections and gonorrhea.